BusinessCURE Pharmaceutical & Therapix Biosciences Signs MOU with Israel’s Assuta Medical Centers to Develop First-in-Class Therapeutic Products in Fields of Personalized Medicine & CannabinoidsBy Nasdaq OMXJul 11, 2017, 1:00 PM UTC
BusinessCURE Pharmaceutical Expects Increased Demand for Its Enhanced Transdermal Drug Delivery PlatformBy Nasdaq OMXJul 5, 2017, 1:00 PM UTC
BusinessPhase 1 clinical trial shows safety and immunogenicity of microneedle patch for flu vaccination for the first timeBy Nasdaq OMXJun 28, 2017, 10:00 AM UTC
BusinessCURE Pharmaceutical Appoints CannaKids CEO and Cannabis Cancer Advocate Tracy Ryan to Advisory BoardBy Nasdaq OMXJun 27, 2017, 1:00 PM UTC
BusinessProLynx announces collaboration with Daiichi Sankyo to evaluate drug delivery system in the eyeBy Nasdaq OMXJun 19, 2017, 1:00 PM UTC
BusinessProLynx announces PLX039, a hydrogel-microsphere drug delivery system that supports once-monthly administration of a GLP-1 receptor agonistBy Nasdaq OMXJun 12, 2017, 1:00 PM UTC
BusinessLeading OTF Manufacturer CURE Pharmaceutical Comments on New Report Showing Exponential Growth in Thin Film Drug Manufacturing MarketBy Nasdaq OMXJun 7, 2017, 3:14 PM UTC
BusinessCURE Pharmaceutical and CannaKids Announce Research Collaboration with Technion-Israel Institute of Technology on Cancer-Fighting CannabinoidsBy Nasdaq OMXMay 31, 2017, 1:04 PM UTC
